Clinical implication of serum uric acid level in pegylated interferon and ribavirin combination therapy for chronic hepatitis C infection

BACKGROUND/AIMS: Combined treatment of pegylated interferon-α (PEG-IFN) and ribavirin (RBV) has long been accepted as the standard treatment for chronic hepatitis C virus (HCV) infection. Many predictive factors for treatment response have been identified. The aim of this study was to evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, In Soo, Won, Joung Won, Kim, Hyung Joon, Lee, Hyun Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668402/
https://www.ncbi.nlm.nih.gov/pubmed/28797159
http://dx.doi.org/10.3904/kjim.2016.405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668402/
https://www.ncbi.nlm.nih.gov/pubmed/28797159
http://dx.doi.org/10.3904/kjim.2016.405

Ejemplares similares